- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00072657
Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis
Behavioral Treatments for Rheumatoid Arthritis
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Rheumatoid arthritis is a progressive inflammatory illness marked by severe functional declines, significant economic and social costs, and significant psychological distress. Environmental and psychosocial factors such as stress, mood disturbance, and coping mechanisms may contribute to changes in important health outcomes, including disability and disease activity in RA. This study will compare CBT with TCC, a relaxation-based intervention, combining elements of slow gentle movement with meditation, against a more traditional health education seminar. Outcome measures will include psychological adaptation, mood disturbance, sleep quality, physiological adaptation, and disease severity.
Two hundred-ten patients will be randomly assigned to either CBT, TCC, or a control group. The CBT intervention will have three phases: 1) education on the nature of the adjustment process in chronic illness, 2) coping skill development, and 3) generalization and application of skills to everyday situations. Participants in the CBT group will attend 12 weekly group sessions of about 2 hours each. Participants in the TCC group will learn to perform 18 movements under the guidance of an expert TCC teacher. TCC participants will have 50 to 60 minute biweekly sessions during the 12-week study. Control group participants will attend weekly group educational sessions; these sessions will provide general knowledge about arthritis health and illness, and will include lectures, demonstrations, and question-and-answer sessions with experts in rheumatology, sleep science, and behavioral medicine.
Participants will be assessed prior to beginning treatment, at mid-treatment (Week 6) and again at the end of treatment (Week 12 to 13). The long term effect of interventions will be assessed at follow-up interviews 4 months and 8 months after the end of formal treatment. Psychosocial adaptation, mood disturbance and sleep quality, self-reported pain, and immune function will be measured at all five assessment periods.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
California
-
Los Angeles, California, Verenigde Staten, 90095
- Cousins Center for Psychoneuroimmunology, UCLA
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Diagnosis of RA as defined by the American College of Rheumatology (ACR) and consistent with revised criteria for RA
- Stable disease-modifying drug regimen for 3 months prior to study entry, with no change in drug dosage for at least 3 months prior to study entry
- Relatively stable disease course for 3 months prior to study entry
- If treated with corticosteroids, must be on a stable dosage for 3 months prior to study entry
- If taking prednisone, must be on a dosage less than or equal to 10 mg/day or equivalent
- Resides in Greater Los Angeles area
Exclusion Criteria:
- Inactive RA conditions defined as "in remission"
- Experiencing frequent, severe disease flares that require changes in primary disease-modifying regimen
- Serious medical conditions, including: diabetes, congestive heart failure, renal failure requiring specific treatment, cancer (unless cured for period of 5 years or more), unregulated endocrine disorders (including thyroid disorders), chronic uncontrolled infection, or any uncontrolled medical condition that may interfere with the study
- Use of analgesics (e.g., opioids) other than acetaminophen or non-steroidal anti-inflammatory agents prescribed for RA treatment, tramadol (Ultram) or Tylenol with codeine on an as-needed basis, or propoxyphen (Darvocet, Wygesic)
- Use of oxycodone (Percocet), hydrocodone (Vicodin), morphine, or hydromorphone (Dilaudid)
- Use of high levels of methotrexate (greater than 7.5 mg)
- Use of nitrogen mustard, cyclosporine, monoclonal antibodies, or cyclophosphamide within the 6 months prior to study entry
- Serious psychiatric conditions, such as bipolar disorder, psychotic disorders, or organic brain syndromes
- At risk for suicide
- Dependent on canes, walkers, or other assistive devices
- Unable to commit to study schedule/itinerary or unwilling to be assigned to any of the 3 treatment groups
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: 1
Participants will partake in cognitive behavioral therapy for 12 weeks.
|
The CBT intervention will have three phases: 1) education on the nature of the adjustment process in chronic illness, 2) coping skill development, and 3) generalization and application of skills to everyday situations.
Participants in the CBT group will attend 12 weekly group sessions of about 2 hours each.
|
Experimenteel: 2
Participants will partake in tai chi chih for 12 weeks.
|
Participants in the TCC group will learn to perform 18 movements under the guidance of an expert TCC teacher.
TCC participants will have 50- to 60-minute biweekly sessions during the 12-week study.
|
Actieve vergelijker: 3
Participants will act as a control and attend educational sessions for 12 weeks.
|
Control group participants will attend weekly group educational sessions; these sessions will provide general knowledge about arthritis health and illness, and they will include lectures, demonstrations, and question-and-answer sessions with experts in rheumatology, sleep science, and behavioral medicine.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Disease activity
Tijdsspanne: Measured at Week 12 and Months 4 and 8 follow-up
|
Measured at Week 12 and Months 4 and 8 follow-up
|
Health functioning
Tijdsspanne: Measured at Week 12 and Months 4 and 8 follow-up
|
Measured at Week 12 and Months 4 and 8 follow-up
|
Inflammation, measured by levels of IL-1, IL-6, and tumor necrosis factor (TNF)-alpha
Tijdsspanne: Measured at Week 12 and Months 4 and 8 follow-up
|
Measured at Week 12 and Months 4 and 8 follow-up
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Mood disturbances
Tijdsspanne: Measured at Week 12 and Months 4 and 8 follow-up
|
Measured at Week 12 and Months 4 and 8 follow-up
|
Coping
Tijdsspanne: Measured at Week 12 and Months 4 and 8 follow-up
|
Measured at Week 12 and Months 4 and 8 follow-up
|
Helplessness
Tijdsspanne: Measured at Week 12 and Months 4 and 8 follow-up
|
Measured at Week 12 and Months 4 and 8 follow-up
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Perry M. Nicassio, PhD, University of California, Los Angeles
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- R01AR049840 (Subsidie/contract van de Amerikaanse NIH)
- NIAMS-095
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Reumatoïde artritis
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital of Zhejiang Chinese Medical University; Zhejiang...Werving
-
Texas Tech University Health Sciences Center, El...Beëindigd
-
Nantes University HospitalVoltooidSeptische arthritisFrankrijk
-
wangxiaodongVoltooid
-
Second Affiliated Hospital, School of Medicine,...VoltooidSeptische arthritisChina
-
Rennes University HospitalVoltooid
-
Assiut UniversityNog niet aan het wervenSeptische arthritis
-
Assiut UniversityNog niet aan het werven
-
Assistance Publique - Hôpitaux de ParisWerving
-
Khoo Teck Puat HospitalOnbekend
Klinische onderzoeken op Cognitive Behavioral Therapy
-
Drexel UniversityVoltooidObesitas | OvergewichtVerenigde Staten
-
The University of Texas Health Science Center at...The Rutgers Asian Resource Center for Minority Aging Research (RCMAR)WervingType 2 diabetesVerenigde Staten
-
Assistance Publique - Hôpitaux de ParisNog niet aan het wervenGehoorverlies | Cognitieve functie | Uitvoerende functie | Vestibulaire functieFrankrijk
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)VoltooidPsychologische spanningVerenigde Staten
-
Microclinic InternationalRoyal Health Awareness Society (RHAS); Jordanian Ministry of Health (MoH)VoltooidHyperglykemie | Hypertensie | Obesitas | Diabetes mellitus, type 2 | Suikerziekte | Suikerziekte | Lichaamsgewicht | Gewichtsverlies | Bloeddruk | Gewichtstoename | Sociaal gedrag | Gewicht, lichaam | Glucose, hoog bloed | Levensstijl, gezond | Gewichtsverandering, lichaam | Gedrag, gezondheid | Risicovermindering van levensstijl en andere voorwaardenJordanië
-
Alexandria UniversityWerving
-
Medical University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)Actief, niet wervendHartinfarct | Afasie | Afasie niet vloeiendVerenigde Staten
-
Utah State UniversityOnbekendTrichotillomanieVerenigde Staten
-
Semra TUNCAY YILMAZSemra TUNCAY YILMAZVoltooidOuderschap | Moeder-foetale relaties | Vaderlijk gedragKalkoen
-
University of VermontVoltooid